These included upregulation SERPINB2, a known oncogene [63–65], and a decrease in TGFβ1 expression, a cytokine which may function under specific circumstances as a tumor suppressor in pancreatic cancer [66–68]. This evidence concerns the gene SERPINB2 and neoplasm.